Q2 Earnings Forecast for SPRY Issued By Leerink Partnrs
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Free Report) – Investment analysts at Leerink Partnrs decreased their Q2 2025 earnings per share estimates for shares of ARS Pharmaceuticals in a research note issued to investors on Wednesday, May 14th. Leerink Partnrs analyst R. Ruiz now expects that the company will earn ($0.43) per share for the quarter, […]
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Free Report) – Investment analysts at Leerink Partnrs decreased their Q2 2025 earnings per share estimates for shares of ARS Pharmaceuticals in a research note issued to investors on Wednesday, May 14th. Leerink Partnrs analyst R. Ruiz now expects that the company will earn ($0.43) per share for the quarter, […]
